Igor L Davydkin

7PUBLICATIONS
32CO-AUTHORS
Haematological tumoursRegenerative medicine (incl. stem cells)Neural engineeringClinimetricsImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 30, 2026
Biomarkers for Monitoring R-CHOP-associated Cardiotoxicity in Patients with Non-hodgkin Lymphoma.

|Oct 26, 2022
[The efficacy and safety of eculizumab biosimilar in patients with paroxysmal nocturnal hemoglobinuria. Results of a phase III randomized open-label comparative clinical trial].

A D Kulagin, B A Bakirov, I L Davydkin

|Aug 16, 2021
Randomized multicenter noninferiority phase III clinical trial of the first biosimilar of eculizumab.

Alexander D Kulagin, Vadim V Ptushkin, Elena A Lukina

|May 26, 2021
[Post-COVID-19 asthenic syndrome].

I A Zolotovskaia, P R Shatskaia, I L Davydkin

|Dec 21, 2020
[Results of phase Ib open multicenter clinical trial of the safety, pharmacokinetics and pharmacodynamics of first biosimilar of eculizumab in untreated patients with paroxysmal nocturnal hemoglobinuria during induction of therapy].

V V Ptushkin, A D Kulagin, E A Lukina

|Jun 30, 2020
[General and particular issues of etiopathogenesis of peptic ulcer and gastric cancer: current status of the problem].

A M Osadchuk, I L Davydkin, T A Gricenko

Pageof 2

Frequent Collaborators

3 joint publications

Vadim V Ptushkin

3 joint publications

Alexander D Kulagin

3 joint publications

Tatyana S Konstantinova

2 joint publications

I A Zolotovskaya